-
-
Call more information
660-596-2224 -
Authors: Yieshan M. Chan, M.D. et al Anesthesiology 8 2016, Vol.125, 431-432. To the Editor: We congratulate Nanji et al.1 for their recent prospective, observational study defining the frequency of medication errors (MEs) and potential adverse drug events (ADEs) in the operating rooms of the Massachusetts General Hospital, Boston, Massachusetts. We read this article with great interest, […]
Read MoreAuthors: James W. Ibinson, M.D., Ph.D. et al Anesthesiology 8 2016, Vol.125, 431. To the Editor: Although thought provoking and likely to lead to significant research in the future, the data presented by Nanji et al.1 are not sufficient to support a conclusion that medication errors (MEs) occurring during the course of anesthesia lead to meaningful harm. A primary […]
Read MoreAuthors: T. Andrew Bowdle, M.D., Ph.D., F.A.S.E. et al Anesthesiology 8 2016, Vol.125, 429-431. To the Editor: The recent article by Nanji et al.1 concerning errors related to anesthetic drug administration is interesting and raises a number of provocative questions. However, we are concerned that the manner in which the data are presented and interpreted may lead readers […]
Read MoreAuthors: Peter A. Chin, M.B.B.S. Anesthesiology 8 2016, Vol.125, 425. To the Editor: I read with interest the report by Beach et al.1 on the relationship between nil per os (NPO) time and major adverse events, with special attention to pulmonary aspiration. The authors conclude that NPO status is not an independent predictor of major complications. As reported […]
Read MoreAuthors: Harsha Shanthanna, M.D. et al Anesthesiology 8 2016, Vol.125, 423-425. To the Editor: We read with interest the study by Turan et al.1 on the use of methylprednisolone for persistent incisional pain after cardiac surgery. This substudy was done on 1,110 of the 7,500 patients included for the Steroid In caRdiac Surgery (SIRS) trial.2 The treatment group […]
Read More